Hemorrhage of brain metastasis from non-small cell lung cancer post gefitinib therapy: two case reports and review of the literature

BACKGROUND: Gefitinib is one of the small molecule inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR TKIs). Clinical trials have demonstrated it is effective for treatment of a subset of patients with advanced non-small cell lung cancer (NSCLC). Gefitinib has been generally consid...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Dan-Fang, Yan, Sen-Xiang, Yang, Jing-Song, Wang, Yi-Xiang J, Sun, Xiao-Li, Liao, Xin-Biao, Liu, Jun-Qing
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2843670/
https://www.ncbi.nlm.nih.gov/pubmed/20170543
http://dx.doi.org/10.1186/1471-2407-10-49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2843670/
https://www.ncbi.nlm.nih.gov/pubmed/20170543
http://dx.doi.org/10.1186/1471-2407-10-49

Ejemplares similares